FDA Approved: RUFINAMIDE — Supplemental Application (Bionpharma Inc.)

View source ↗

Summary

FDA approves a supplemental application for Rufinamide from Bionpharma Inc., updating the approved product under a supplemental submission.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lennox-gastaut Syndrome

Drugs mentioned

• Rufinamide (Rufinamide)

Snippet

SUPPL AP for RUFINAMIDE (RUFINAMIDE)